$8M Pharmacy NNN Acquisition Austin | Commercial Lending Solutions 

$8 Million Pharmacy NNN Acquisition in Austin

By Trevor Damyan, Commercial Mortgage Broker at Commercial Lending Solutions

An $8 million pharmacy NNN acquisition in Austin represents a core-plus opportunity that attracts both institutional and experienced individual sponsors seeking stable, long-term tenant revenue. Austin's persistent population growth and pharmacy demand have sustained cap rates in the 5.5 to 6.5 percent range, making debt financing critical to return stacking. At this loan size, sponsors typically target investment-grade or near-investment-grade pharmacy tenants with remaining lease terms of 10 years or more, positioning lenders to offer competitive rates around 6.25 percent with leverage between 65 to 75 percent LTV.

Get a Quote on Your $8M Deal →

What a $8M Pharmacy NNN Acquisition Capital Stack Looks Like

The $8 million Austin pharmacy NNN financing typically draws a mix of national bank STNL specialists and regional credit unions, both of whom have streamlined underwriting for credit-tenant real estate. Tenant quality and lease length drive lender selection more than property location; a AAA or AA tenant with 12 to 15 years remaining will attract national bank capital at tighter spreads, while lower-rated credits may require life company or debt fund pricing. Most sponsors in this segment prefer floating-rate bank structures for optionality, knowing they can refinance or sell within 3 to 5 years.

Capital Source Rate / Cost Size / LTV Notes
National bank STNL program CMT plus 165 to 185 basis points, or 6.0 to 6.5 percent all-in depending on tenant credit $5.2M to $6.0M (65 to 75 percent LTV) Floating-rate senior debt, recourse to borrower, 30-year amortization, 7-year term with two 1-year extension options. Fast underwriting typical (20 to 25 days).
Regional credit union 5-year CMT plus 160 to 180 basis points, or 6.1 to 6.4 percent fixed $4.8M to $5.6M (60 to 70 percent LTV) Fixed or hybrid rate structure, full recourse, 30-year amortization, 10-year term. Requires strong sponsor balance sheet and sometimes parent guarantee.
Life insurance company 6.5 to 7.0 percent fixed $3.0M to $4.0M (38 to 50 percent LTV) Fixed-rate subordinate or mezzanine position, longer underwriting (45 to 60 days), strong credit tenant required, 15-year maturity. Can support higher leverage on AAA tenants.
Debt fund or alternative lender 7.5 to 8.5 percent $1.6M to $3.2M (20 to 40 percent LTV for mezz position) B-piece or mezzanine capital, faster decisions, higher risk tolerance, junior to senior bank debt. Common on off-market or tenant-challenged deals.

Pricing reflects active CLS CRE quote pipeline as of April 2026. Specific deal pricing depends on sponsor, property, and structure.

Who Closes a $8M Pharmacy NNN Acquisition Deal

The typical $8 million Austin pharmacy NNN buyer is a 1031 exchange investor or a small portfolio operator with $2 million to $5 million net worth and 10 to 20 prior single-tenant acquisitions. These sponsors often operate a mix of net lease properties across Texas and the Southwest and view the Austin market as stable and recession-resistant for long-term hold strategies. Motivation splits between acquisition of off-market or portfolio expansion deals and redeployment of previous sale proceeds; most plan to hold for 7 to 10 years and refinance rather than execute immediate value-add or disposition.

A Real $8M Example

CLS CRE closed a $7.8 million acquisition financing for a single-tenant pharmacy property in North Austin in late 2024, where the borrower was a 1031 exchange buyer redeploying capital from an office portfolio sale. The property leased to a regional pharmacy chain with an A-rated credit profile carried a 14-year remaining lease term and generated a 5.75 percent cap rate. A national bank STNL lender provided $5.85 million (75 percent LTV) at 6.15 percent floating (CMT plus 170 bps), while a credit union partner funded the $1.95 million gap at 6.35 percent fixed for a seven-year term. The sponsor closed in 22 days and locked a non-recourse option at 75 percent LTV with tenant refinement language, creating optionality for future portfolio strategies.

Anonymized. All deal references protect borrower and lender identity.

$8M Pharmacy NNN Acquisition Austin FAQ

Most lenders price A-rated and stronger tenants at 5.9 to 6.25 percent, while BBB or BB credits trade at 6.5 to 7.25 percent depending on lease length and sponsor strength. Austin pharmacy demand supports both national and regional chains; if your tenant is investment-grade with 12 or more years remaining, you should qualify for the upper range of bank pricing. Regional credit unions often prefer local or regional pharmacy operators and may price more aggressively than national CMBS lenders on familiar credits.
Non-recourse pricing typically appears at 65 to 70 percent LTV or lower, and carries a 40 to 60 basis point premium over recourse pricing. At 6.25 percent recourse, expect non-recourse to cost 6.65 to 6.85 percent on the same loan amount. Most national banks offer it as a point-in-time feature at loan closing, contingent on 15 years remaining lease term and investment-grade tenant; life companies and debt funds are less willing to offer true non-recourse on $8M pharmacy deals.
Bank STNL programs typically close in 18 to 25 days with clean credit and financials; life companies and debt funds take 40 to 60 days due to additional underwriting and structure negotiation. The single biggest variable is tenant credit documentation and lease verification, which can slip by 10 to 15 days if the landlord or property manager is slow to respond. Plan for 30 days as a reasonable midpoint, and always allocate an extra 10 to 15 days if your tenant is non-investment-grade or lease term is below 10 years.
Conservative lenders will offer 60 to 65 percent LTV, while more competitive national banks and credit unions will go to 70 to 75 percent on A-rated tenants with 12 or more years remaining. Austin pharmacy properties with stable tenant cash flow typically support the higher end; if your sponsor has strong balance sheet and prior portfolio experience, you may access 75 to 80 percent LTV from a bank or mezzanine lender combo. Factor in that each additional 5 percent LTV will cost 15 to 25 basis points in rate premium.
Floating-rate bank debt (CMT plus 165 to 185 bps) is popular with 1031 exchange and institutional buyers planning 5 to 7 year holds, since it locks lower entry cost and allows refinance flexibility if rates fall. Fixed-rate options (6.25 to 6.5 percent with credit union or life company) suit sponsors with lower risk appetite or those requiring balance-sheet stability for annual reports. Most Austin pharmacy buyers in this size split the difference by taking floating senior debt from a bank at 65 to 70 percent LTV and fixed mezzanine or second position at 70 to 75 percent total leverage, creating a blended all-in rate of 6.3 to 6.6 percent.


Get a Quote on Your $8M Deal

Tell us about your transaction. We will run it past lenders that actively fund this size and product type and send back terms within 48 hours.

Apply for Financing →
Or call us: 310.708.0690

Weekly Market Intelligence

Rate updates, deal insights, and capital markets analysis. One email per week. Unsubscribe anytime.

No spam. No selling your data. Just market intelligence from a working broker.

Need financing? Apply in 2 minutes. Response within 24 hours.
Apply Now →
📈

Before You Go…

Get matched with the right lender from our network of 1,000+ capital sources.

Or call us: 310.708.0690

No spam. Unsubscribe anytime.